Table 1. Studies reporting melanoma growth in patients undergoing treatment with biologics [7-13,16]
Authors |
Biological Therapy |
Number of melanoma |
Journal and year |
Setoguchi S et al. |
Not specified |
1 |
Arthrit & Rheum, 2006 |
Lebas D et al. |
“TNF-alpha blockers” |
1 |
Ann Derm Venereol, 2007 |
Wolfe F et al. |
Infliximab Etanercept Adalimumab Anakinra |
11 9 1 2 |
Arch Rheum, 2007 |
Khan I et al. |
Infliximab |
1 |
Clin and Exper Dermatol, 2009 |
Dreyer L et al. |
“TNF-alpha blockers” |
3 |
Ugeskr Laeger, 2009 |
Kowalzick L et al. |
Infliximab+Adalimumab+ Etanercept |
1 |
Hautartz, 2009 |
Katoulis AC et al. |
Adalimumab |
2 |
Dermatology, 2010 |
Hacard Fet al. |
Etanercept |
1 |
Ann Derm Venereol, 2010 |
Manganoni AM et al. |
Eculizumab |
2 |
Ann Hematol, 2011 |